B

Baptist Memorial Health Care | Baptist Clinical Research Institute

Research site
(Unclaimed)
Location
6141 Walnut Grove Road Second Floor, Memphis, Tennessee, United States of America
Site insights

Top conditions

Lung Cancer (4 trials)

Cancer (3 trials)

Breast Cancer (2 trials)

Leukemia (1 trial)

Neoplasm Metastasis (1 trial)

Top treatments

Etavopivat
Vorolanib
D-Ribose
9-ING-41
Nivolumab
INB03
Sacituzumab
AVM0703
Calaspargase Pegol

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

8 of 14
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
9-ING-41 in Patients With Advanced Cancers

GSK-3β is a potentially important therapeutic target in human malignancies. The Actuate 1801 Phase 1/2 study is designed to evaluate the safety and e...

Active, not recruiting
Neoplasm of Lung
Neoplasms Pancreatic
Drug: Gemcitabine - 21 day cycle
Drug: Lomustine

The purpose of this study is to evaluate the safety and efficacy of etavopivat (FT-4202) for the treatment of anemia in adult patients with very low...

Enrolling
Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R
Drug: Etavopivat

The purpose of this phase 2/3 study is to confirm the recommended doses and to evaluate the safety and pharmacodynamics of Calaspargase pegol for the...

Enrolling
Acute Lymphoblastic Leukemia
Drug: Calaspargase pegol (S95015)

This is a two-agent, open-label, non-randomized, Phase 1/2 dose escalation and dose expansion study of combinatorial oral vorolanib plus infusional n...

Active, not recruiting
Non-small Cell Lung Cancer
Refractory Thoracic Tumors
Drug: Vorolanib
Biological: Nivolumab

This trial is being conducted to evaluate the efficacy of Phasix™ Mesh implantation at the time of midline fascial closure compared to primary suture...

Enrolling
Open Midline Laparotomy
Device: Phasix™ Mesh

This study will randomize patients recently discharged from the hospital with a confirmed diagnosis of type 1 acute myocardial infarction (Thygesen e...

Invitation-only
Acute Myocardial Infarction
Combination Product: Placebo
Combination Product: Selatogrel

The goal of this clinical study is to compare the study drug, sacituzumab govitecan-hziy (SG), versus docetaxel in participants with advanced or meta...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Docetaxel
Biological: Sacituzumab Govitecan-hziy (SG)

This is an open-label, Phase 1/2 study designed to characterize the safety, tolerability, Pharmacokinetics(PK), and preliminary antitumor activity of...

Enrolling
Lymphoid Malignancies
Drug: AVM0703

Trial sponsors

A

AVM Biotechnology (1 trial)

Forma Therapeutics logo

Forma Therapeutics (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems